BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18444251)

  • 1. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
    Hursting SD; Perkins SN; Lavigne JA; Beltran L; Haines DC; Hill HL; Alvord WG; Barrett JC; DiGiovanni J
    Mol Carcinog; 2009 Aug; 48(8):671-7. PubMed ID: 19415693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
    Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
    Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
    Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Lampidonis AD; Anastasiou D; Kachrilas S; Messini-Nikolaki N; Papassideri IS; Aravantinos G; Margaritis LH; Voutsinas GE
    Int J Oncol; 2009 Jan; 34(1):137-60. PubMed ID: 19082486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K
    Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members.
    Morita S; Shirakata Y; Shiraishi A; Kadota Y; Hashimoto K; Higashiyama S; Ohashi Y
    Mol Vis; 2007 Nov; 13():2119-28. PubMed ID: 18079685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.
    Lu Y; Liu P; Van den Bergh F; Zellmer V; James M; Wen W; Grubbs CJ; Lubet RA; You M
    Cancer Prev Res (Phila); 2012 Feb; 5(2):248-59. PubMed ID: 21982874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice.
    Leung WK; Wu KC; Wong CY; Cheng AS; Ching AK; Chan AW; Chong WW; Go MY; Yu J; To KF; Wang X; Chui YL; Fan DM; Sung JJ
    Carcinogenesis; 2008 Aug; 29(8):1648-54. PubMed ID: 18611916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India.
    Gangwar R; Mandhani A; Mittal RD
    Surgery; 2011 Jan; 149(1):126-34. PubMed ID: 20627335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of oral submucous fibrosis using oligonucleotide microarray.
    Hu Y; Jian X; Peng J; Jiang X; Li N; Zhou S
    Oncol Rep; 2008 Aug; 20(2):287-94. PubMed ID: 18636188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
    Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of insulin-like growth factor-I-induced changes in messenger ribonucleic acid expression in cultured porcine granulosa cells: possible role of insulin-like growth factor-I in angiogenesis.
    Grado-Ahuir JA; Aad PY; Ranzenigo G; Caloni F; Cremonesi F; Spicer LJ
    J Anim Sci; 2009 Jun; 87(6):1921-33. PubMed ID: 19251926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
    Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P
    Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.
    Angelucci A; Garofalo S; Speca S; Bovadilla A; Gravina GL; Muzi P; Vicentini C; Bologna M
    Endocr Relat Cancer; 2008 Mar; 15(1):91-100. PubMed ID: 18310278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.